Clinical trial
Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the…
NCT00317629 · Fundación Cardiovascular de Colombia, Other · Terminated
Key facts
| NCT number | NCT00317629 |
|---|---|
| Title | Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis |
| Official title | Double Blind, Randomized Controlled Trial, to Evaluate the Effectiveness of a Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis |
| Lead sponsor | Fundación Cardiovascular de Colombia, Other |
| Collaborators | Universidad de Antioquia The University of Akron Universidad de Santander Secretaria de Salud de Santander Secretaria de Salud de Tolima |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cutaneous Leishmaniasis |
| Intervention type | Drug |
| Interventions | controlled nitric oxide releasing patch, meglumine antimoniate |
| Enrollment | 178 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Apr 25, 2006 |
| Last update posted | Nov 24, 2010 |
| Countries | Colombia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: